- Home
- YMAB vs DHY Comparison
YMAB vs DHY Comparison
Compare YMAB & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- DHY
- Stock Information
- Founded
- YMAB 2015
- DHY 1998
- Country
- YMAB United States
- DHY United States
- Employees
- YMAB N/A
- DHY N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- DHY Finance/Investors Services
- Sector
- YMAB Health Care
- DHY Finance
- Exchange
- YMAB Nasdaq
- DHY Nasdaq
- Market Cap
- YMAB 192.4M
- DHY 211.3M
- IPO Year
- YMAB 2018
- DHY N/A
- Fundamental
- Price
- YMAB $4.32
- DHY $2.14
- Analyst Decision
- YMAB Buy
- DHY
- Analyst Count
- YMAB 11
- DHY 0
- Target Price
- YMAB $17.55
- DHY N/A
- AVG Volume (30 Days)
- YMAB 182.8K
- DHY 569.1K
- Earning Date
- YMAB 08-11-2025
- DHY 01-01-0001
- Dividend Yield
- YMAB N/A
- DHY 9.10%
- EPS Growth
- YMAB N/A
- DHY N/A
- EPS
- YMAB N/A
- DHY N/A
- Revenue
- YMAB $88,658,000.00
- DHY N/A
- Revenue This Year
- YMAB N/A
- DHY N/A
- Revenue Next Year
- YMAB $15.15
- DHY N/A
- P/E Ratio
- YMAB N/A
- DHY N/A
- Revenue Growth
- YMAB 4.92
- DHY N/A
- 52 Week Low
- YMAB $3.55
- DHY $1.77
- 52 Week High
- YMAB $16.11
- DHY $2.08
- Technical
- Relative Strength Index (RSI)
- YMAB 43.02
- DHY 65.63
- Support Level
- YMAB $4.23
- DHY $2.12
- Resistance Level
- YMAB $4.62
- DHY $2.00
- Average True Range (ATR)
- YMAB 0.24
- DHY 0.02
- MACD
- YMAB -0.03
- DHY 0.00
- Stochastic Oscillator
- YMAB 14.04
- DHY 98.67
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.